[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Stereotaxis Inc (STXS)

Stereotaxis Inc (STXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 130,252
  • Shares Outstanding, K 97,934
  • Annual Sales, $ 32,380 K
  • Annual Income, $ -21,640 K
  • EBIT $ -22 M
  • EBITDA $ -21 M
  • 60-Month Beta 1.37
  • Price/Sales 3.81
  • Price/Cash Flow N/A
  • Price/Book 8.55

Options Overview Details

View History
  • Implied Volatility 133.08% (-54.82%)
  • Historical Volatility 63.93%
  • IV Percentile 60%
  • IV Rank 23.78%
  • IV High 404.93% on 03/09/26
  • IV Low 48.26% on 08/11/25
  • Expected Move (DTE 17) 0.0425 (3.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 38
  • Volume Avg (30-Day) 190
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 5,312
  • Open Int (30-Day) 4,364
  • Expected Range 1.3725 to 1.4575

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.03
  • Number of Estimates 1
  • High Estimate $-0.03
  • Low Estimate $-0.03
  • Prior Year $-0.05
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2400 +15.73%
on 07/31/26
1.9400 -26.03%
on 07/07/26
-0.3550 (-19.83%)
since 07/02/26
3-Month
1.2400 +15.73%
on 07/31/26
2.1000 -31.67%
on 05/28/26
-0.4650 (-24.47%)
since 05/04/26
52-Week
1.2400 +15.73%
on 07/31/26
3.5900 -60.03%
on 10/09/25
-0.8550 (-37.34%)
since 08/04/25

Most Recent Stories

More News
Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors

AUSTIN, Texas, Aug. 03, 2026 (GLOBE NEWSWIRE) --  Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor...

INSP : 63.21 (+21.05%)
STXS : 1.4600 (+9.77%)
MOBI : 11.67 (+2.78%)
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026

ST. LOUIS, July 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...

STXS : 1.4600 (+9.77%)
University of Szeged Pioneers First Robotic Cardiology Program in Hungary

First Robotic Magnetic Navigation system installed in Hungary University of Szeged, led by Cardiology Chief Dr. Szili-Torok, expected to treat hundreds of patients annually with all forms of cardiac arrhythmia...

STXS : 1.4600 (+9.77%)
Stereotaxis Completes Acquisition of Robocath

ST. LOUIS and ROUEN, France, July 09, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced...

STXS : 1.4600 (+9.77%)
Stereotaxis Q1 Earnings Call Highlights

Stereotaxis (NYSEAMERICAN:STXS) said its first-quarter results did not yet reflect what management described as a major commercial transition driven by new regulatory approvals, new catheter products and...

STXS : 1.4600 (+9.77%)
Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates

Proprietary robotically-navigated MAGiC catheter received U.S. FDA approval in January and is now being utilized at multiple sites across the United States as well as Europe Synchrony digital operating...

STXS : 1.4600 (+9.77%)
Stereotaxis Announces First MAGiC Procedures in the United States

ST. LOUIS, April 22, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients...

STXS : 1.4600 (+9.77%)
Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026

ST. LOUIS, April 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...

STXS : 1.4600 (+9.77%)
Stereotaxis Announces Definitive Agreement to Acquire Robocath

ST. LOUIS and ROUEN, France, April 15, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced...

STXS : 1.4600 (+9.77%)
Stereotaxis Announces FDA Clearance and Launch of Synchrony System

ST. LOUIS, April 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has...

STXS : 1.4600 (+9.77%)

Business Summary

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to allow physicians to navigate catheters, guidewires...

See More

Key Turning Points

3rd Resistance Point 1.4667
2nd Resistance Point 1.4233
1st Resistance Point 1.3767
Last Price 1.4600
1st Support Level 1.2867
2nd Support Level 1.2433
3rd Support Level 1.1967

See More

52-Week High 3.5900
Fibonacci 61.8% 2.6923
Fibonacci 50% 2.4150
Fibonacci 38.2% 2.1377
Last Price 1.4600
52-Week Low 1.2400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.